Related Experiment Video
Updated: Sep 2, 2025

Genome-Wide Analysis of DNA Methylation in Gastrointestinal Cancer
Published on: September 18, 2020
Molecular and clinicopathological analysis of three cases of gastric juvenile polyposis
Yuya Yamashiro1, Yuka Yanai1, Tsutomu Takeda2
1Department of Human Pathology Juntendo University School of Medicine Tokyo Japan.
Background And Aim:
Juvenile polyposis (JP) is a rare disease known to be associated with mutations either in SMAD4/BMPR1A. JP is known to often develop into malignant tumors, with a reported probability of 9-50%. However, the mechanisms of its carcinogenesis are not fully understood. We tried to elucidate the mechanisms of malignant transformation underlying this condition in three cases of gastric JP.
Methods:
We selected polyps from each patient displaying varying degrees of atypia and their nearby normal polyps and compared them using immunohistochemistry, Sanger sequencing, and loss of heterozygosity (LOH) analysis of SMAD4, BMPR1A, and TP53.
Results:
Two of the three cases were suspected of having germline SMAD4 mutations based on their familial medical histories; the remaining case was found to have a SMAD4 germline mutation following preoperative genetic testing. All three cases were shown to present with both SMAD4 positive and negative areas across each lesion, with the neoplastic lesions tending to show stronger nuclear SMAD4 expression. This expression was closely associated with the SMAD4 LOH status; however, we also noted paradoxical SMAD4 expression in the neoplastic lesions despite the biallelic inactivation of SMAD4 revealed in the genetic evaluation.
Conclusions:
These data suggest that strong nuclear expression of SMAD4, even when seemingly paradoxical, seems to be closely associated with dysplastic polyps in JP. Complete inactivation of SMAD4 was not shown to be essential for the development of dysplastic polyps in gastric JP, and other pathways seemed to be involved in the acquisition of the malignant phenotype.
Insights
Juvenile polyposis (JP) involves SMAD4 mutations and carries a high cancer risk. Our study shows SMAD4 expression, even paradoxical, is linked to gastric JP dysplasia, suggesting other pathways drive malignancy.
Area of Science:
- Gastroenterology
- Oncology
- Genetics
Background:
- Juvenile polyposis (JP) is a rare condition linked to SMAD4/BMPR1A mutations.
- JP has a significant risk of malignant transformation (9-50%), but carcinogenesis mechanisms are unclear.
Purpose of the Study:
- To investigate the molecular mechanisms of malignant transformation in gastric Juvenile Polyposis.
- To elucidate the role of SMAD4 and BMPR1A in the progression of gastric JP.
Main Methods:
- Analyzed gastric polyps from three JP patients with varying atypia using immunohistochemistry, Sanger sequencing, and LOH analysis.
- Focused on SMAD4, BMPR1A, and TP53 genes.
Main Results:
- All three cases had SMAD4 germline mutations or strong suspicion thereof.
- SMAD4 expression varied within lesions, with stronger nuclear expression in neoplastic areas, correlating with SMAD4 LOH status.
- Paradoxical SMAD4 expression was observed even with biallelic SMAD4 inactivation.
Conclusions:
- Strong nuclear SMAD4 expression, even if paradoxical, is associated with dysplastic polyps in gastric JP.
- Complete SMAD4 inactivation is not essential for gastric JP polyp development.
- Other molecular pathways likely contribute to the malignant phenotype in JP.
More Related Videos
Related Concept Videos
Gastritis-II: Pathophysiology
In acute gastritis, the gastric mucosa becomes swollen and red and undergoes superficial erosion. Superficial ulceration may lead to bleeding.
In chronic gastritis, persistent or repeated insults lead to chronic inflammatory changes and, eventually, thinning or atrophy of the gastric tissue.
Gastritis can stem from various causes, each...
Barrett Esophagus-II: Clinical Manifestations and Management
To diagnose Barrett's esophagus, healthcare providers often recommend an endoscopy for those showing symptoms of acid reflux. The procedure...
Barrett Esophagus-I: Introduction
This constant acid exposure transforms the esophagus's pink mucosal lining (stratified squamous epithelium) into a type of lining more...
Peptic Ulcer Disease II: Pathophysiology
Damaging agents such as Helicobacter pylori, gastric acid, pepsin, and nonsteroidal anti-inflammatory drugs (NSAIDs) can weaken the mucosal defense, allowing hydrogen ions to infiltrate back and harm epithelial cells.
Peptic Ulcer Disease III: Clinical Manifestations and Diagnostic Studies
Few clinical manifestations differentiate gastric ulcers from duodenal ulcers. Distinctions in the location, timing, and pain relief are crucial for healthcare providers in differentiating between gastric and duodenal ulcers during clinical assessments.
Gastric Motility
Peristaltic Waves and Chyme Formation
Upon food entry, the stomach initiates...

